UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: human microbiome

Microbiome R&D & Business Collaboration Forum presentation slides

Following the Microbiome R&D & Business Collaboration Forum, we have made the following presentation slides from Karoline Faust, Dirk Hadrich, Lesley Hoyles & Jos Seegers available.

Read More

The top 4 challenges for microbiome companies – NIZO

Microbiome research is abundant and profoundly inspiring. Whether focusing on cancer drug response, or the more classical field of gut discomfort solutions, we are clearly on the brink of some long-anticipated breakthroughs. But despite the promise, companies in the field face challenges.

Read More

How does Maternal Microbiome composition influence offspring metabolic outcomes?

Professor Margaret Morris is Chair and Head of Pharmacology, School of Medical Sciences, University of NSW. Her research explores the underlying brain mechanisms in epilepsy, obesity, diabetes, and the link between obesity and high blood pressure. We recently asked her about her research into obesity and the microbiome.

Read More

Looking beyond the bacterial gut microbiome

Most microbiome research to date has focused on the bacterial gut microbiome, and yet microbiomes are comprised of a wide array of microbes – from viruses and archaea to protozoa and yeasts – and colonize nearly every human body site – from the skin and lungs to the urogenital system and breast milk.

Read More

The conundrum with animal models of the human microbiome

The most that can be expected from any model is that it can supply a useful approximation to reality: All models are wrong; some models are useful.

This aphorism, simply articulated here by prominent British statistician George Box, gets to the crux of the dilemma we face when considering animal models for the study of human microbiome dynamics and mechanisms.

Read More

The Emerging Market of the Human Microbiome

The human microbiome is an area of life sciences that is gaining traction in the venture capital community. According to the Wall Street Journal, venture capital investment in microbiome companies rose 458.5 percent to 114.5 million U.S. dollars during the period from 2011 – 2015.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive